Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

F1213-BC RPMI 1640 Liquid Medium

with 2.0 g/l NaHCO₃, without L-glutamine

RPMI 1640 Liquid Medium MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
F1213-BC
  
Purchase on Sigma-Aldrich

Přehled

Replacement Information
Description
OverviewRPMI 1640 medium was developed by Moore and his co-workers while at Roswell Park Memorial Institute in 1966. Originally designed for the growth of human leukaemia cells in monolayer or suspension cultures using a serum supplement, it has since demonstrated universal use in the growth and support of a broad spectrum of mammalian and hybrid cells as well as in hybridoma fusion protocols. For peripheral blood lymphocytes a mixture of 80% RPMI 1640 and 20% FBS is often used, and for murine myeloma cells a mixture of 85% RPMI and 15% FBS.
Specifications:

Sterility: Pass
BHK 21 Cell Proliferation Test: Pass
BHK 21 Cell Cloning Efficicency Test: Pass
pH: 6.9-7.5
Osmolality: 0.26-0.29 Osm/kg H20
Endotoxin: <0.5 EU/ml
Color: Red
Appearance: Clear
Catalogue NumberF1213-BC
Brand Family Calbiochem®
References
ReferencesHam, R.G. et al. 1979. Meth. Enzymol. 53, 44.
Moore, G.E. et al. 1976. TCA Manual. 3, 503.
Moore, G.E. et al. 1968. NY. State J. Med. 68, 2054.
Moore, G.E. et al. 1967. JAMA. 199, 519.
Moore, G.E. et al. 1967. XXI, Ann. Symp. Fand. Canc. Res. Feb. 41.
Product Information
Applications
Biological Information
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Blue Ice Only
Storage +2°C to +8°C
Do not freeze Ok to freeze
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalogové číslo GTIN
F1213-BC 0

Documentation

References

Přehled odkazů
Ham, R.G. et al. 1979. Meth. Enzymol. 53, 44.
Moore, G.E. et al. 1976. TCA Manual. 3, 503.
Moore, G.E. et al. 1968. NY. State J. Med. 68, 2054.
Moore, G.E. et al. 1967. JAMA. 199, 519.
Moore, G.E. et al. 1967. XXI, Ann. Symp. Fand. Canc. Res. Feb. 41.